Success in intrauterine insemination: The role of etiology

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 7, 2007, Pages 855-860

  Ahinko Hakamaa, Katja ^a   Huhtala, Heini ^a,b   Tinkanen, Helena ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Etiology; IUI; Pregnancy rate; Prognostic factor

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; CLOMIFENE CITRATE; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ANOVULATION; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; INFERTILITY; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MATERNAL AGE; MULTIPLE PREGNANCY; OVARY FOLLICLE CELL; OVARY HYPERSTIMULATION; PREDICTOR VARIABLE; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPERMATOZOON COUNT;

ADULT; AGE FACTORS; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY; INSEMINATION, ARTIFICIAL, HOMOLOGOUS; MALE; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDIES; SPERM COUNT;

EID: 34447129609     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701416895     Document Type: Article

References (21)

1. Garceau L, Henderson J, Davis LJ, Petrou S, Henderson LR, McVeigh E, et al. Economic implications of assisted reproductive techniques: a systematic review. Hum Reprod. 2002;17:3090-109.
2. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet. 2000;355:13-8.
3. Philips Z, Barraza-Llorens M, Posnett J. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod. 2000;15:95-106.
4. Claman P, Wilkie V, Collins D. Timing intrauterine insemination either 33 or 39 hours after administration of human chorionic gonadotropin yields the same pregnancy rates as after superovulation therapy. Fertil Steril. 2004;82:13-6.
5. Iberico G, Vioque J, Ariza N, Lozano JM, Roca M, Llacer J, et al. Analysis of factors influencing pregnancy rates in homologous intrauterine insemination. Fertil Steril. 2004;81:1308-13.
6. Stone BA, Vargyas JM, Ringler GE, Stein AL, Marrs RP. Determinants of the outcome of intrauterine insemination: Analysis of outcomes of 9963 consecutive cycles. Am J Obstet Gynecol. 1999;180:1522-34.
7. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in sub-fertility: An analysis of factors affecting outcome. Hum Reprod. 1999;14:698-703.
8. Tomlinson MJ, Amissah-Arthur JB, Thompson KA, Kasraie JL, Bentick B. Prognostic indicators for intrauterine insemination (IUI): Statistical model for IUI success. Hum Reprod. 1996;11:1892-6.
9. Ghosh C, Buck G, Priore R, Wacktawski-Wende J, Severino M. Follicular response and pregnancy among infertile women undergoing ovulation induction and intrauterine insemination. Fertil Steril. 2003;80:328-35.
10. Lee RK, Hou JW, Ho HY, Hwu YM, Lin MH, Tsai YC, et al. Sperm morphology analysis using strict criteria as a prognostic factor in intrauterine insemination. Int J Androl. 2002;25:277-80.
11. van Weert JM, Repping S, Van Voorhis BJ, van der Veen F, Bossuyt PM, Mol BW. Performance of the postwash total motile sperm count as a predictor of pregnancy at the time of intrauterine insemination: a meta-analysis. Fertil Steril. 2004;82:612-20.
12. Balasch J. Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility. Reprod Biomed Online. 2004;9:664-72.
13. Collins J. Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. current best evidence for the advanced treatment of unexplained subfertility. Hum Reprod. 2003;18:907-12.
14. Hughes EG. Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. 'effective treatment' or 'not a natural choice'? Hum Reprod. 2003;18:912-4.
15. Ombelet W, Deblaere K, Bosmans E, Cox A, Jacobs P, Janssen M, et al. Semen quality and intrauterine insemination. Reprod Biomed Online. 2003;7:485-92.
16. Khalil MR, Rasmussen PE, Erb K, Laursen SB, Rex S, Westergaard LG. Homologous intrauterine insemination. an evaluation of prognostic factors based on a review of 2473 cycles. Acta Obstet Gynecol Scand. 2001;80:74-81.
17. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH. Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone. Hum Reprod. 1993;8:56-9.
18. Ryan GL, Moss V, Davis WA, Sparks AE, Dokras A, Van Voorhis BJ. Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness. J Reprod Med. 2005;50:943-50.
19. Papageorgiou TC, Guibert J, Savale M, Goffinet F, Fournier C, Merlet F, et al. Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination. BJOG. 2004;111:1277-82.
20. Werbrouck E, Spiessens C, Meuleman C, D'Hooghe T. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril. 2006;86:566-71.
21. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril. 2002;78:1088-95.